|
|
|
Insider
Information: |
Tate Jeffrey |
Relationship: |
Chief Operating Office... |
City: |
High Springs |
State: |
FL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
92,042 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$128,859 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
92,042 |
|
|
Total
Value |
$128,859 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
4
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-0.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cyclo Therapeutics, Inc |
CYTH |
Chief Operating Office... |
2023-10-20 |
92,042 |
2014-08-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYTH |
Cyclo Therapeutics, Inc |
Chief Executive Officer |
|
2014-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
540,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Executive Officer |
|
2014-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
560,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
COO and CSO |
|
2016-06-06 |
4 |
B |
$0.00 |
$0 |
D/D |
100,000 |
660,972 |
2.73 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
COO and CSO |
|
2016-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
680,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
COO and CSO |
|
2017-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
700,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
COO & Chief Scientific Officer |
|
2017-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
720,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
COO & Chief Scientific Officer |
|
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
740,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
COO & Chief Scientific Officer |
|
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
840,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
COO & Chief Scientific Officer |
|
2018-12-26 |
4 |
B |
$0.00 |
$0 |
D/D |
25,000 |
865,972 |
2.73 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2019-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
965,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2020-04-24 |
4 |
A |
$0.10 |
$5,000 |
D/D |
50,000 |
1,015,972 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,160 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2021-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
25,160 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2021-03-29 |
4 |
B |
$7.50 |
$15,000 |
D/D |
2,000 |
27,160 |
2.81 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2022-04-28 |
4 |
B |
$2.50 |
$1,588 |
D/D |
635 |
27,795 |
2.73 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2022-04-29 |
4 |
B |
$2.70 |
$3,692 |
D/D |
1,365 |
29,160 |
2.73 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2022-05-16 |
4 |
B |
$2.12 |
$6,354 |
D/D |
3,000 |
32,160 |
2.81 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2023-04-20 |
4 |
B |
$0.71 |
$21,258 |
D/D |
29,941 |
62,101 |
2.81 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Operating Officer |
|
2023-10-20 |
4 |
OE |
$0.71 |
$21,258 |
D/D |
29,941 |
92,042 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|